Insulin Therapy and Autoimmune Disease with Relevance to Nonalcoholic Fatty Liver Disease

Ian Martins

Research output: Contribution to conferenceAbstractpeer-review


The diabetes epidemic is now expected by the year 2050 to become a global pandemic with approx. 592 million affected in both the developed and developing world. The treatment of diabetes by insulin therapy has been the focus for many diabetics with the improvement and prevention of various diseases such as cardio¬vascular disease, kidney disease and neurodegeneration. The global nonalcoholic fatty liver disease (NAFLD) epidemic has now become of major concern to diabetes with critical interest in insulin therapy to reverse and stabilize autoimmune disease with relevance to NAFLD and the diabetes pandemic. Dietary components that acti¬vate anti-aging genes improve insulin therapy and should be assessed with specific amounts and doses of Indian spices consumed that may not interfere with insulin therapy and induce mitophagy in various diseases. Food quality, appetite control and core body temperature are critical to maintain insulin therapy with unhealthy diets linked to NAFLD and diabetes. Genomic medicine and dietary activators are essential to maintain insulin therapy and prevent toxic immune reactions with relevance to NAFLD and diabetes management.

Original languageEnglish
Publication statusPublished - 17 Apr 2019
EventPathology 2019, April 17-18, Tokyo, Japan - Tokyo, Japan
Duration: 17 Apr 201918 Apr 2019


ConferencePathology 2019, April 17-18, Tokyo, Japan


Dive into the research topics of 'Insulin Therapy and Autoimmune Disease with Relevance to Nonalcoholic Fatty Liver Disease'. Together they form a unique fingerprint.

Cite this